| Analysis | Metabolite Name | Measured Value | Units | AGE | Assay | DISEASE_STATE | Timepoint |
|---|---|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 152430 | Peak area normalized | 14 | BC TP | Control | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 154278 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 163987 | Peak area normalized | 13 | BC TP | Control | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 190983 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 198659 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 208111 | Peak area normalized | 13 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 209487 | Peak area normalized | 16 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 212315 | Peak area normalized | 13 | OGTT | Control | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 216502 | Peak area normalized | 12 | OGTT | Control | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 233192 | Peak area normalized | 17 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 245666 | Peak area normalized | 14 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 256521 | Peak area normalized | 16 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 257820 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 261544 | Peak area normalized | 14 | OGTT | Control | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 268109 | Peak area normalized | 12 | BC TP | Control | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 276071 | Peak area normalized | 16 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 282438 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 283338 | Peak area normalized | 15 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 293178 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 297912 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 334490 | Peak area normalized | 13 | BC TP | Control | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 335433 | Peak area normalized | 12 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 338095 | Peak area normalized | 13 | OGTT | Control | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 348687 | Peak area normalized | 12 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 362603 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 404577 | Peak area normalized | 15 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 418651 | Peak area normalized | 12 | BC TP | Control | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 450427 | Peak area normalized | 16 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 452609 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 461698 | Peak area normalized | 13 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 471616 | Peak area normalized | 15 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 525366 | Peak area normalized | 15 | BC TP | Control | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 552816 | Peak area normalized | 12 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 564452 | Peak area normalized | 12 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 575323 | Peak area normalized | 15 | OGTT | PCOS | 90 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 582254 | Peak area normalized | 16 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 590207 | Peak area normalized | 16 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 606587 | Peak area normalized | 12 | OGTT | Control | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 614079 | Peak area normalized | 17 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 645380 | Peak area normalized | 17 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 755288 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 814758 | Peak area normalized | 12 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 894110 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 909114 | Peak area normalized | 15 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 918965 | Peak area normalized | 13 | OGTT | Control | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 946589 | Peak area normalized | 16 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 974457 | Peak area normalized | 13 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1014262 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1021609 | Peak area normalized | 16 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1060868 | Peak area normalized | 12 | BC TP | Control | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1107812 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1165835 | Peak area normalized | 13 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1182760 | Peak area normalized | 13 | BC TP | Control | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1193889 | Peak area normalized | 13 | OGTT | Control | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1207416 | Peak area normalized | 16 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1228155 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1255241 | Peak area normalized | 15 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1291186 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1424099 | Peak area normalized | 14 | BC TP | Control | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1447184 | Peak area normalized | 12 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1465091 | Peak area normalized | 14 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1476869 | Peak area normalized | 12 | OGTT | Control | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1539934 | Peak area normalized | 17 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1547302 | Peak area normalized | 16 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1575266 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1668337 | Peak area normalized | 15 | OGTT | PCOS | 30 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1697461 | Peak area normalized | 14 | OGTT | Control | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1830676 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1858544 | Peak area normalized | 12 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1896897 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1897320 | Peak area normalized | 15 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 1949822 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 2018351 | Peak area normalized | 12 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 2025130 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 2069994 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 2078919 | Peak area normalized | 12 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 2081614 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 2155867 | Peak area normalized | 12 | BC TP | Control | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 2189198 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 2212430 | Peak area normalized | 16 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 2241164 | Peak area normalized | 12 | OGTT | Control | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 2242056 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 2259476 | Peak area normalized | 15 | BC TP | Control | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 2379768 | Peak area normalized | 16 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 2443782 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 2692743 | Peak area normalized | 12 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 2751187 | Peak area normalized | 13 | BC TP | Control | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 3220379 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 3721988 | Peak area normalized | 12 | OGTT | PCOS | - |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|